Trial
NCT04042506
SBRT as a Vaccination for Metastatic Melanoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Collaborators
Bristol-Myers Squibb
Condition
Metastatic Melanoma
Intervention
Nivolumab 10 MG/ML Intravenous Solution [OPDIVO]
Why stopped
Unable to enroll patients in this study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-04-12